Lisa Su sells 125,000 AMD shares under 10b5‑1 (AMD)

Rhea-AI Filing Summary

AMD executive reported an at‑the‑market sale plan execution. The filing states 125,000 shares of Common Stock were sold on 02/11/2026 under a 10b5‑1 plan for proceeds of $26,794,757.00. The filing also lists 42,148 RSU/PSU dated 08/09/2024 and 42,852 previously exercised options dated 06/06/2023 as securities described in the notice.

The sale is reported for Lisa Su and is characterized as a Rule 10b5‑1 sale; the filing shows the sale date and gross proceeds but does not provide further timing or planned future activity.

Insights

Insider Transactions Analyst

Executive sale under a 10b5‑1 plan: 125,000 shares sold for $26.79M.

The notice records a 10b5‑1 sale by Lisa Su on 02/11/2026

as reported: 125,000 shares with proceeds of $26,794,757.00. The filing also lists 42,148 RSU/PSU and 42,852 previously exercised options as securities referenced in the form. These latter counts are descriptive items in the notice and are not presented as additional open market transactions in this excerpt.

Cash‑flow treatment and any ongoing trading plan parameters are not shown in the excerpt; subsequent filings would provide further disclosures if transactions continue.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85000	17410550.00	1630410843	03/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2024	RSU/PSU	Issuer			42148	08/09/2024	N/A
Common	06/06/2023	Previously Exercised Stock Options	Issuer			42852	06/06/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA SU 2485 Augustine Drive Santa Clara CA 95054	Common	02/11/2026	125000	26794757.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the AMD (AMD) Form 144 report disclose?

The Form 144 reports a 10b5‑1 sale of 125,000 shares on 02/11/2026. The filing lists gross proceeds of $26,794,757.00 and references RSUs and previously exercised options as described securities.

Who is the reporting person named in the AMD Form 144?

The filing names Lisa Su as the reporting person linked to the 10b5‑1 sale. The notice identifies the transactions as 10b5‑1 sales and gives the reporting address shown in the excerpt.

How many and what types of securities are listed in the AMD notice?

The excerpt lists a sale of 125,000 Common shares, 42,148 RSU/PSU dated 08/09/2024, and 42,852 previously exercised options dated 06/06/2023. The RSU/option counts are descriptive in the form.

Does the AMD Form 144 state the proceeds received from the sale?

Yes; the filing shows gross proceeds of $26,794,757.00 associated with the 125,000 share sale on 02/11/2026. The excerpt does not allocate net proceeds or uses of funds.

Was the sale in the AMD Form 144 executed under a trading plan?

The filing characterizes the transaction as a 10b5‑1 sale, indicating it was effected under a prearranged trading plan. The excerpt does not disclose the plan’s start/end dates or remaining schedule.